A Nasopharyngeal Cancer Patient in Xinjiang, China, Receives Intratumoral Chlorine Dioxide Injection

A Nasopharyngeal Cancer Patient in Xinjiang, China, Receives Intratumoral Chlorine Dioxide Injection

Today, a nasopharyngeal cancer patient in Xinjiang, China, underwent intratumoral chlorine dioxide injection therapy administered by a local doctor. The patient’s tumor measured approximately 4 cm in diameter, and according to clinical guidelines, a 10ml high-concentration chlorine dioxide injection was recommended. However, as it was the doctor’s first time performing the procedure, only 2ml was injected initially to ensure safety. The patient is currently in stable condition.

This marks the second case in China receiving intratumoral chlorine dioxide therapy. The first case took place in Beijing, where I personally treated a British patient. Although the tumor shrunk significantly after the injection, the patient was overly anxious and opted for focused ultrasound ablation, which ultimately led to a severe skin rupture and infection.

For this nasopharyngeal cancer patient, the procedure was conducted at a legitimate clinic by a professional doctor and was preceded by anesthesia. This treatment was carried out in a more standardized manner than the previous case, and I am highly confident that, with multiple injections, the tumor will be completely eradicated.

Despite being Chinese, I am still unable to offer this therapy to patients within China.

China has a highly stringent medical regulatory system, where all drugs must be officially approved. Any doctor administering unapproved treatments risks legal consequences. This nasopharyngeal cancer case in Xinjiang remains an isolated instance, with the doctor taking on considerable risks to perform the procedure.

So why did this doctor take such a risk? The reasons are clear:

✅ He trusts my therapy and the medication I provided.

✅ He has a strong relationship with the patient, ensuring the best possible outcome for them.

I will continue to track and report the progress of this nasopharyngeal cancer case.